Next FDA commissioner will prioritize regulatory stability within 6 months

Pharma executives explicitly called for a leader who can calm regulatory uncertainty. A new commissioner is expected to issue policy guidance or public statements reaffirming consistency in drug approvals.

Implied probability (Yes)

70%